Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y011019 | — |
No adverse event; HCP called to report inadvertent administration of VARIVAX after a temperature excursion. Vaccine was administered on 04MAR2025 to a patient. Limited demographics provided. No additional AE/PQC. No additional information. ? Names of vacc; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. HCP called to report inadvertent administration of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE) (dose, units, and route of administration were not reported) (lot #Y011019, expiration date: 18-Jun-2026) for prophylaxis after a temperature excursion (Product storage error). Vaccine was administered on 04-MAR-2025 to a patient. Temperature excursion was reported as follows: -12.13C for a time frame of 0 hours 39 minutes 0 seconds. Previous temperature excursion of -14.19C for 9 minutes; and -14.25C for 16 minutes. There was no additional AE/PQC (No adverse event).
Sterile diluent